Download PDF
Semin Liver Dis 2001; 21(2): 179-194
DOI: 10.1055/s-2001-15495
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Radionuclide Imaging of Hepatic and Biliary Disease

Eugene C. Lin, Christopher C. Kuni
  • Department of Radiology, University of Colorado Health Sciences Center, Denver, Colorado
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

This article will focus on common clinical applications of scintigraphy in focal hepatic lesions, acute cholecystitis, biliary dyskinesia, biliary obstruction, postoperative liver and biliary tract, and neonatal cholestasis. The utility of positron emission tomography will also be addressed.

KEYWORD

Biliary tract - liver - positron emission tomography - radionuclide imaging - scintigraphy

REFERENCES

  • 1 Krishnamurthy G, Krishnamurthy S. Imaging agents. In: Krishnamurthy G, Krishnamurthy, S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 33-58
    Google Scholar
  • 2 Kuni C C, Klingensmith W C. Focal nodular hyperplasia in Budd-Chiari syndrome. In: Kuni CC, Klingensmith WC, eds. Atlas of Radionuclide Hepatobilary Imaging Boston: G.K. Hall Medical Publishers 1983: 56-57
    Google Scholar
  • 3 Piers D, Houthoff H, Krom R. Hot spot liver scan in focal nodular hyperplasia.  Am J Roentgenol . 1980;  135 1289-1292
    PubMedGoogle Scholar
  • 4 Lubbers P, Ros P, Goodman Z, Ishak K. Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation.  Am J Roentgenol . 1987;  148 1105-1108
    PubMedGoogle Scholar
  • 5 Kinnard M, Alavi A, Rubin R, Lichenstein G. Nuclear imaging of solid hepatic masses.  Semin Roentgenol . 1995;  30 375-395
    PubMedGoogle Scholar
  • 6 Rogers J, Mack L, Freeny P, Johnson M, Sones P. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy.  Am J Roentgenol . 1981;  137 983-990
    PubMedGoogle Scholar
  • 7 Welch T, Sheedy P, Johnson C. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy.  Radiology . 1985;  156 593-595
    PubMedGoogle Scholar
  • 8 Kudo M, Ikekubo K, Yamamoto K. Distinction between hemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPECT scanning.  Am J Roentgenol . 1989;  152 977-983
    PubMedGoogle Scholar
  • 9 Nelson R C, Chezmar J L. Diagnostic approach to hepatic hemangiomas.  Radiology . 1990;  176 11-13
    PubMedGoogle Scholar
  • 10 Birnbaum B, Weinreb J, Megibow A. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT.  Radiology . 1990;  176 95-101
    PubMedGoogle Scholar
  • 11 Sostre S, Villagra D, Morales N, Rivera J. Dual-tracer scintigraphy and subtraction studies in the diagnosis of hepatocellular carcinoma.  Cancer . 1988;  61 667-672
    PubMedGoogle Scholar
  • 12 Serafini A, Jeffers L, Reddy K, Heiba S, Schiff E. Early recognition of recurrent hepatocellular carcinoma utilizing gallium-67 citrate scintigraphy.  J Nucl Med . 1988;  29 712-716
    PubMedGoogle Scholar
  • 13 Fonseca C, Greenberg D, Rosenthall L, Arzoumanian A. Assessment of the utility of gallbladder imaging with 99m-Tc-IDA.  Clin Nucl Med . 1978;  3 437-441
    PubMedGoogle Scholar
  • 14 Freitas J, Gulati M. Rapid evaluation of acute abdominal pain by hepatobiliary scanning.  JAMA . 1980;  244 1585-1587
    CrossrefPubMedGoogle Scholar
  • 15 Krishnamurthy G, Krishnamurthy S. Acute cholecystitis. In: Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 211-225
    Google Scholar
  • 16 Matolo N, Stadalnik R, Dixon S. Value and limitations of scanning of the biliary tract.  Surg Gynecol Obstet . 1980;  150 521-524
    PubMedGoogle Scholar
  • 17 Mauro M, McCartney W, Melmud J. Hepatobiliary scanning with 99m-Tc-PIPIDA in acute cholecystitis.  Radiology . 1982;  142 193-197
    PubMedGoogle Scholar
  • 18 Szlabick R, Catto J, Fink-Bennett D, Ventura V. Hepatobiliary scanning in the diagnosis of acute cholecystitis.  Arch Surg . 1980;  115 540-544
    PubMedGoogle Scholar
  • 19 Weissmann H, Badia J, Sugarman L. Spectrum of 99m-Tc-IDA cholescintigraphic patterns in acute cholecystitis.  Radiology . 1981;  138 167-175
    PubMedGoogle Scholar
  • 20 Choy D, Shi E, McLean R. Cholescintigraphy in acute cholecystitis: use of intravenous morphine.  Radiology . 1984;  151 203-307
    PubMedGoogle Scholar
  • 21 Fig L, Stewart R, Wahl R, Shapiro B. Potential pitfalls in the use of morphine hepatobiliary scintigraphy.  J Nucl Med (Abst). 1989;  30 850
    PubMedGoogle Scholar
  • 22 Keslar P, Turbiner E. Hepatobiliary imaging and the use of intravenous morphine.  Clin Nucl Med . 1987;  12 592-596
    PubMedGoogle Scholar
  • 23 Kim E, Pjura G, Lowry P, Nguyen M, Pollack M. Morphine-augmented cholescintigraphy in the diagnosis of acute cholecystitis.  Am J Roentgenol . 1986;  147 1177-1179
    PubMedGoogle Scholar
  • 24 Kim C, Tse K, Juweid M, Mozley P, Woda A, Alavi A. Cholescintigraphy in the diagnosis of acute cholecystitis: morphine augmentation is superior to delayed imaging.  J Nucl Med . 1993;  34 1866-1870
    PubMedGoogle Scholar
  • 25 Kistler A, Ziessman H, Gooch D, Bitterman P. Morphone-augmented cholescintigraphy in acute cholecystitis: a satisfactory alternative to delayed imaging.  Clin Nucl Med . 1991;  16 404-406
    PubMedGoogle Scholar
  • 26 Fink-Bennett D, Balon H, Robbins T, Tsai D. Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis.  J Nucl Med (Abst) . 1989;  30 850
    PubMedGoogle Scholar
  • 27 Mehta A, Alazraki N. The effectiveness of morphine in expediting the radionuclide diagnosis of acute cholecystitis.  J Nucl Med (Abst). 1987;  28 596
    PubMedGoogle Scholar
  • 28 Vasquez T, Greenspan G, Evans D, Halpern S, Ashburn W. Clinical efficacy of intravenous morphine administration in hepatobiliary imaging for acute cholecystitis.  Clin Nucl Med . 1988;  13 4-6
    PubMedGoogle Scholar
  • 29 Cabana M, Alavi A, Berlin J. Morphine-augmented hepatobiliary scintigraphy: a meta-analysis.  Nucl Med Commun . 1995;  16 1068-1071
    PubMedGoogle Scholar
  • 30 Samuels B, Freitas J, Bree R, Schwab R, Heller S. A comparison of radionuclide hepatobiliary imaging and real-time ultrasound for the detection of acute cholecystitis.  Radiology . 1983;  147 207-210
    PubMedGoogle Scholar
  • 31 Shea J, Berlin J, Escarce J. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease.  Arch Intern Med . 1994;  154 2573-2581
    CrossrefPubMedGoogle Scholar
  • 32 Kurtz A, Middleton W. Gallbladder. In: Kurtz A, Middleton W, eds. Ultrasound: The Requisites St. Louis: Mosby-Year Book 1996: 35-54
    Google Scholar
  • 33 Shuman W, Rogers J, Rudd T. Low sensitivity of sonography and cholescintigraphy in acalculous cholecystitis.  Am J Roentgenol . 1984;  142 531-534
    PubMedGoogle Scholar
  • 34 Mirvis S, Vainright J, Nelson A. The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT.  Am J Roentgenol . 1986;  147 1171-1175
    PubMedGoogle Scholar
  • 35 Prevot N, Mariat G, Mahul P. Contribution of cholescintigraphy to the early diagnosis of acute acalculous cholecystitis in intensive-care-unit patients.  Eur J Nucl Med . 1999;  26 1317-1325
    CrossrefPubMedGoogle Scholar
  • 36 Ramanna L, Brachman M, Tanasescu D, Berman D, Waxman A. Cholescintigraphy in acute acalculous cholecystitis.  Am J Gastroenterol . 1984;  79 650-653
    PubMedGoogle Scholar
  • 37 Swayne L. Acute acalculous cholecystitis: sensitivity in detection using technetium-99m iminodiacetic acid cholescintigraphy.  Radiology . 1986;  160 33-38
    PubMedGoogle Scholar
  • 38 Weissmann H, Berkowitz D, Fox M. The role of technetium-99m imunodiacetic acid (IDA) cholescintigraphy in acute acalculous cholecystitis.  Radiology . 1983;  146 177-180
    PubMedGoogle Scholar
  • 39 Krishnamurthy G, Krishnamurthy S. Biliary dyskinesia. In: Krishnamurthy G, Krishnamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 235-245
    Google Scholar
  • 40 Ziessman H. Diagnosis of chronic acalculous cholecystitis using cholecystokinin cholescintigraphy: methodology and interpretation. In: Freeman L, ed. Nuclear Medicine Annual Philadelphia: Lippincott Williams & Wilkins 1999: 99-119
    Google Scholar
  • 41 Krishnamurthy G, Krishnamurthy S. Cystic duct syndrome (chronic acalculous cholecystitis). In: Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer; 2000: 199-210
    Google Scholar
  • 42 Fink-Bennett D, DeRidder P, Kolozsi W. Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease.  J Nucl Med . 1991;  32 1695-1699
    PubMedGoogle Scholar
  • 43 Yap L, Wycherley A, Morphett A, Toouli J. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy.  Gastroenterology . 1991;  101 786-793
    PubMedGoogle Scholar
  • 44 Toper T, Tyerson T, Nora P. Quantitative gallbladder imaging following cholecyostokinin.  J Nucl Med . 1980;  21 694-696
    PubMedGoogle Scholar
  • 45 Pickelman J, Peiss R, Henkin R. The role of sincalide cholescintigraphy in the evaluation of patients with acalculous gallbladder disease.  Arch Surg . 1985;  120 693-697
    PubMedGoogle Scholar
  • 46 Zech E, Simmons L, Kendrick R. Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladder.  Surg Gynecol Obstet . 1991;  172 2124-2126
    PubMedGoogle Scholar
  • 47 Reed D, Fernandez M, Hicks R. Kinevac-assisted cholescintigraphy as an accurate predictor of chronic acalculous gallbladder disease and the likelihood of symptom relief with cholecystectomy.  Am J Surg . 1993;  59 273-277
    PubMedGoogle Scholar
  • 48 Mishkind M, Pruitt R, Bambini D. Effectiveness of cholecystokinin-cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.  Ann Surg . 1997;  63 769-774
    PubMedGoogle Scholar
  • 49 Sorenson M, Fancer S, Lang N. Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia.  Am J Surg . 1993;  166 672-674
    PubMedGoogle Scholar
  • 50 Middleton G, Williams J. Is gallbladder ejection fraction a reliable predictor of acalculous gallbladder disease?.  Nucl Med Commun . 1992;  13 894-896
    PubMedGoogle Scholar
  • 51 Halverson J, Garner B, Siegel B. The use of hepatobiliary scintigraphy in patients with acalculous biliary colic.  Arch Intern Med . 1992;  152 1305-1307
    CrossrefPubMedGoogle Scholar
  • 52 Ziessman H. Cholecystokinin cholescintigraphy: victim of its own success?.  J Nucl Med . 1999;  40 2038-2042
    PubMedGoogle Scholar
  • 53 Krishnamurthy S, Krishnamurthy G. Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin.  J Nucl Med . 1997;  38 1824-1830
    PubMedGoogle Scholar
  • 54 Dodds W, Thakur S, Collier R. Quantitative hepatobiliary scintigraphy.  J Nucl Med . 1990;  31 1468-1469
    PubMedGoogle Scholar
  • 55 Fullarton G, Hilditch T, Campbell A, Murray W. Clinical and scintigraphic assessment of the role of endoscopic sphinterotomy in the treatment of sphincter of Oddi dysfunction.  Gut . 1990;  31 231-235
    PubMedGoogle Scholar
  • 56 Shaffer E, Hershfield N, Logan K, Kloiber R. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi: effect of papillotomy.  Gastroenterology . 1986;  90 728-733
    PubMedGoogle Scholar
  • 57 Cicala M, Scopinaro F, Corzziari E. Quantitative cholescintigraphy in the assessment of choledochoduodenal bile flow.  Gastroenterology . 1991;  100 1106-1113
    PubMedGoogle Scholar
  • 58 Madacsy L, Velosy B, Lonovics J, Csernay L. Differentiation between organic and functional dyskinesia of the sphincter of Oddi with amyl nitrate-augmented quantitative hepatobiliary scintigraphy.  Eur J Nucl Med . 1994;  21 203-208
    PubMedGoogle Scholar
  • 59 Sostre S, Kalloo A, Spiegler E, Camargo E, Wagner Jr H. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score.  J Nucl Med . 1992;  33 1216-1222
    PubMedGoogle Scholar
  • 60 Kalloo A, Sostre S, Meyerrose G, Pasricha P, Szabo Z. Gallbladder ejection fraction: nondiagnostic for sphincter of Oddi dysfunction in patients with intact gallbladders.  Clin Nucl Med . 1994;  19(8) 713-719
    PubMedGoogle Scholar
  • 61 Ruffolo T, Sherman S, Lehman G, Hawes R. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction.  Dig Dis Sci . 1994;  39 289-292
    PubMedGoogle Scholar
  • 62 Bar-Meir S, Chamovitz D. 99mTc-DISIDA versus endoscopic biliary manometry in assessing sphincter of Oddi function.  Hepatology . 1989;  10 895-896
    PubMedGoogle Scholar
  • 63 Lee R, Gregg J, Koroshetz A, Hill T, Clouse M. Sphincter of Oddi stenosis: diagnosis using hepatobiliary scintigraphy and endoscopic manometry.  Radiology . 1985;  156 793-796
    PubMedGoogle Scholar
  • 64 Krishnamurthy G, Krishnamurthy S. Extrahepatic cholestasis. In: Krishnamurthy G, Krishnamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases.Berlin: Springer; 2000: 159-187
    Google Scholar
  • 65 Klingensmith W C, Kuni C C, Fritzberg A R. Cholescintigraphy in extrahepatic biliary obstruction.  Am J Roentgenol . 1982;  139 65-70
    PubMedGoogle Scholar
  • 66 Kuni C C, Klingensmith W C, Fritzberg A R. Evaluation of intrahepatic cholestasis with Tc-99m-labeled radiopharmaceuticals.  Gastrointest Radiol . 1984;  9 163-166
    CrossrefPubMedGoogle Scholar
  • 67 Larar G N, Tumeh S. Intrahepatic versus extrahepatic cholestasis in hepatobiliary scintigraphy.  J Nucl Med . 1992;  33 1186-1190
    PubMedGoogle Scholar
  • 68 Brugge W, Alavi A. Cholescintigraphy in the diagnosis of the complications of laparoscopic cholecystectomy.  Semin Ultrasound CT MR . 1993;  14 368-374
    PubMedGoogle Scholar
  • 69 Weissmann H, Gliedman M, Wilk P. Evaluation of the postoperative patient with 99m-Tc-IDA cholescintigraphy.  Semin Nucl Med . 1982;  12 27-52
    PubMedGoogle Scholar
  • 70 Rayter Z, Tonge C, Bennett C, Thomas M, Robinson P. Ultrasound and HIDA: scanning in evaluating bile leaks after cholecystectomy.  Nucl Med Commun . 1991;  12 197-202
    CrossrefPubMedGoogle Scholar
  • 71 Brugge W, Rosenberg D, Alavi A. Diagnosis of postoperative bile leaks.  Am J Gastroenterol . 1994;  89 2178-2183
    PubMedGoogle Scholar
  • 72 Walker A, Shapiro A, Brooks D, Braver J, Tumeh S. Bile duct disruption and biloma after laparoscopic cholecystectomy: imaging evaluation.  Am J Roentgenol . 1992;  158 785-789
    PubMedGoogle Scholar
  • 73 Sandoval B, Goettler C, Robinson A, O'Donnell J, Adler L, Stellato T. Cholescintigraphy in the diagnosis of bile leak after laparoscopic cholecystectomy.  Am Surg . 1997;  63 611-616
    PubMedGoogle Scholar
  • 74 Estrada W, Zanzi I, Ward R, Negrin J, Margouleff D. Scintigraphic evaluation of postoperative complications of laparoscopic cholecystectomy.  J Nucl Med . 1991;  32 1910-1911
    PubMedGoogle Scholar
  • 75 Peters J, Ollila D, Nichols K. Diagnosis and management of bile leaks following laparoscopic cholecystectomy.  Surg Laparosc Endosc . 1994;  4 163-170
    PubMedGoogle Scholar
  • 76 Scott-Smith W, Raftery A, Wraight E, Calne R. Tc-99m labeled HIDA imaging in suspected biliary leaks after liver transplantation.  Clin Nucl Med . 1983;  8 478-479
    PubMedGoogle Scholar
  • 77 Kurzawinski T, Selves L, Farouk M. Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantation.  Br J Surg . 1997;  84 620-623
    Google Scholar
  • 78 Anselmi M, Lancberg S, Deakin M. Assessment of the biliary tract after liver transplantation: T tube cholangiography or IODIDA scanning.  Br J Surg . 1990;  77 1233-1237
    PubMedGoogle Scholar
  • 79 Lantsberg S, Lanchbury E, Drolc Z. Evaluation of bile duct complications after orthotopic liver transplantation by hepatobiliary scanning.  Nucl Med Commun . 1990;  11 761-769
    PubMedGoogle Scholar
  • 80 Banzo I, Blanco I, Gutierrez-Mendiguchia C. Hepatobiliary scintigraphy for the diagnosis of bile leaks produced after T-tube removal in orthotopic liver transplantation.  Nucl Med Commun . 1998;  19 229-236
    PubMedGoogle Scholar
  • 81 Mochizuki T, Tauxe W, Dobkin J. Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy.  Ann Nucl Med . 1991;  5 103-107
    PubMedGoogle Scholar
  • 82 Von Moll L, Juni J, Merion R. Scintigraphic demonstration of accessory hepatic duct leak following liver transplantation.  J Nucl Med . 1988;  29 259-262
    PubMedGoogle Scholar
  • 83 Gilsdorf J, Phillips M, McLeod M. Radionuclide evaluation of bile leakage and the use of subhepatic drains after cholecystectomy.  Am J Surg . 1986;  151 259-262
    CrossrefPubMedGoogle Scholar
  • 84 Frakes J, Bradley S. Endoscopic stent placement for biliary leak from an accessory duct of Luschka after laparoscopic cholecystectomy.  Gastrointest Endosc . 1993;  39 90-92
    PubMedGoogle Scholar
  • 85 Ralph-Edwards T, Himal H. Bile leak after laparoscopic cholecystectomy.  Surg Endosc . 1992;  6 33-35
    CrossrefPubMedGoogle Scholar
  • 86 Jenkins M, Ponsky J, Lehman G. Treatment of bile leaks from the cystohepatic ducts after laparoscopic cholecystectomy.  Surg Endosc . 1994;  8 193-196
    CrossrefPubMedGoogle Scholar
  • 87 Kuni C. Scintigraphy in liver transplants. In: Letourneau J, Day D, Ascher N, eds. Radiology of Organ Transplantation St. Louis: Mosby-Year Book 1991: 170-178
    Google Scholar
  • 88 Kuni C, Engeler C, Nakhleh R, duCret R, Boudreau R. Correlation of technetium-99m-DISIDA hepatobiliary studies with biopsies in liver transplant patients.  J Nucl Med . 1991;  32 1545-1547
    PubMedGoogle Scholar
  • 89 Engeler C, Kuni C, Nakhleh R, Engeler C, duCret R, Boudreau R. Liver transplant rejection and cholestasis: comparison of technetium 99m-diisopropyl iminodiacetic acid hepatobiliary imaging with liver biopsy.  Eur J Nucl Med . 1992;  19 865-870
    PubMedGoogle Scholar
  • 90 Brunot B, Petras S, Germain P, Vinee P, Constantinesco A. Biopsy and quantitative hepatobiliary scintigraphy in the evaluation of liver transplantation.  J Nucl Med . 1994;  35 1321-1327
    PubMedGoogle Scholar
  • 91 Loken M, Ascher N, Boudreau R, Najarian J. Scintigraphic evaluation of liver transplant function.  J Nucl Med . 1986;  27 451-459
    PubMedGoogle Scholar
  • 92 Hawkins R, Hall T, Gambhir S. Radionuclide evaluation of liver transplants.  Semin Nucl Med . 1988;  18 199-212
    PubMedGoogle Scholar
  • 93 Ekman M, Fjalling M, Friman S, Carlson S, Volkmann R. Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers.  Nucl Med Commun . 1996;  17 235-242
    PubMedGoogle Scholar
  • 94 Shah A, Dodson F, Fung J. Role of nuclear medicine in liver transplantation.  Semin Nucl Med . 1995;  25 36-48
    Google Scholar
  • 95 Williams H, Pope C, Siskind B, Lange R, Flye M. Vascular thrombosis in acute hepatic allograft-rejection: scintigraphic appearance.  J Nucl Med . 1985;  26 478-481
    PubMedGoogle Scholar
  • 96 Dalen K, Day D, Ascher N. Imaging of vascular complications after hepatic transplantation.  Am J Roentgenol . 1988;  150 1285-1290
    PubMedGoogle Scholar
  • 97 Brown R, Memsic L, Busuttil R. Accurate demonstration of hepatic infarction in liver transplant recipients.  J Nucl Med . 1986;  27 1428-1431
    PubMedGoogle Scholar
  • 98 Gelfand M, Smith H, Ryckman F. Hepatobiliary scintigraphy in pediatric liver transplant recipients.  Clin Nucl Med . 1992;  17 542-549
    PubMedGoogle Scholar
  • 99 Krishnamurthy G, Krishnamurthy S. Congenital biliary atresia. In: Krishnamurthy G, Krishamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer; 2000: 250-268
    Google Scholar
  • 100 Majd M, Reba R, Altman R. Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice.  Pediatrics . 1981;  67 140-145
    PubMedGoogle Scholar
  • 101 Gerhold J, Klingensmith W R, Kuni C. Diagnosis of biliary atresia with radionuclide hepatobiliary imaging.  Radiology . 1983;  146 499-504
    PubMedGoogle Scholar
  • 102 Manolaki A, Larcher V, Mowat A. The prelaparotomy diagnosis of extrahepatic biliary atresia.  Arch Dis Child . 1983;  58 591-594
    PubMedGoogle Scholar
  • 103 Tolia V, Dubois R, Kagalwalla A. Comparison of radionuclear scintigraphy and liver biopsy in the evaluation of neonatal cholestatis.  J Pediatr Gastroenterol Nutr . 1986;  5 30-45
    PubMedGoogle Scholar
  • 104 Spivak W, Sarkar S, Winter D. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis.  J Pediatr . 1987;  110 855-861
    PubMedGoogle Scholar
  • 105 Park W, Choi S, Lee H. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis.  J Pediatr Surg . 1997;  32 1555-1559
    CrossrefPubMedGoogle Scholar
  • 106 Majd M, Reba R, Altman R. Effect of phenobarbital on 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice.  Semin Nucl Med . 1981;  11 194-204
    PubMedGoogle Scholar
  • 107 Cox K, Stadalnik R, McGahan J. Hepatobiliary scintigraphy with technetium-99m disofenin in the evaluation of neonatal cholestasis.  J Pediatr Gastroenterol Nutr . 1987;  6 885-891
    PubMedGoogle Scholar
  • 108 Gilmour S, Hershkop M, Reifen R, Gilday D, Roberts E. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome.  J Nucl Med . 1997;  38 1279-1282
    PubMedGoogle Scholar
  • 109 Johnson K, Alton H, Chapman S. Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice.  Pediatr Radiol . 1998;  28 937-941
    CrossrefPubMedGoogle Scholar
  • 110 Ben-Haim S, Seabold J, Kao S, Johnson J, Tran D, Brown B. Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice.  Clin Nucl Med . 1995;  20 153-163
    CrossrefPubMedGoogle Scholar
  • 111 Summerville D, Marks M, Treves S. Hepatobiliary scinitgraphy in arteriohepatic dysplasia (Alagille's syndrome): a report of two cases.  Pediatr Radiol . 1988;  18 32-40
    PubMedGoogle Scholar
  • 112 Lin W, Lin C, Changlai S, Shen Y, Wang S. Comparison technetium of Tc-99m disofenin cholescintigraphy with ultrasonography in the differentiation of biliary atresia from other forms of neonatal jaundice.  Pediatr Surg Int . 1997;  12 30-33
    PubMedGoogle Scholar
  • 113 Abramson S, Treves S, Teele R. The infant with possible biliary atresia: evaluation of ultrasound and nuclear medicine.  Pediatr Radiol . 1982;  12 1-5
    CrossrefPubMedGoogle Scholar
  • 114 Delbeke D. Oncological applications of FDG PET imaging brain tumors, colorectal cancer lymphoma and melanoma.  J Nucl Med . 1999;  40 591-603
    PubMedGoogle Scholar
  • 115 Hustinx R, Paulus P, Jacquet N. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases.  Ann Oncol . 1998;  9 397-401
    CrossrefPubMedGoogle Scholar
  • 116 Delbeke D, Vitola J, Sandler M. Staging recurrent metastatic colorectal carcinoma with PET.  J Nucl Med . 1997;  38 1196-1201
    PubMedGoogle Scholar
  • 117 Boykin K, Zibari G, Lilien D. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.  Am Surg . 1999;  65 1183-1185
    PubMedGoogle Scholar
  • 118 Vitola J, Delbeke D, Sandler M. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.  Am J Surg . 1996;  171 21-26
    CrossrefPubMedGoogle Scholar
  • 119 Lai D, Fulham M, Stephen M. The role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.  Arch Surg . 1996;  131 703-707
    PubMedGoogle Scholar
  • 120 Frohlich A, Diederichs C, Staib L. Detection of liver metastases from pancreatic cancer using FDG PET.  J Nucl Med . 1999;  40 250-255
    PubMedGoogle Scholar
  • 121 Nakamoto Y, Higashi T, Sakahara H. Contribution of PET in the detection of liver metastases from pancreatic tumours.  Clin Radiol . 1999;  54 248-252
    CrossrefPubMedGoogle Scholar
  • 122 Trojan J, Schroeder O, Raedle J. Fluorine-18 FDG positron emission tomography fopr imaging of hepatocellular carcinoma.  Am J Gastroenterol . 1999;  94 3314-3319
    CrossrefPubMedGoogle Scholar
  • 123 Delbeke D, Martin W, Sandler M. Evaluation of benign versus malignant hepatic lesions with positron emission tomography.  Arch Surg . 1998;  133 510-516
    CrossrefPubMedGoogle Scholar
  • 124 Khan M, Combs C, Brunt E. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.  J Hepatology . 2000;  32 792-797
    CrossrefPubMedGoogle Scholar
  • 125 Schroder O, Trojan J, Zeuzem S, Baum R. Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.  Nuklearmedizin . 1998;  37 279-285
    PubMedGoogle Scholar
  • 126 Nagata Y, Yamamoto K, Hiraoka M. Monitoring liver tumor therapy with [18F] FDG positron emission tomography.  J Comput Assist Tomogr . 1990;  14 370-374
    PubMedGoogle Scholar
  • 127 Okazumi S, Isono K, Enomoto K. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.  J Nucl Med . 1992;  33 333-339
    PubMedGoogle Scholar
  • 128 Torizuka T, Tamaki N, Inokuma T. In vivo assessent of glucose metabolism in hepatocellular carcinoma with FDG-PET.  J Nucl Med . 1995;  36 1811-1817
    PubMedGoogle Scholar
  • 129 Keiding S, Hansen S, Rasmussen H. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.  Hepatology . 1998;  28 700-706
    CrossrefPubMedGoogle Scholar
  • 130 Iwata Y, Shiomi S, Sasaki N. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.  Ann Nucl Med . 2000;  14 121-126
    PubMedGoogle Scholar
  • 131 Findlay M, Young H, Cunningham D. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.  J Clin Oncol . 1996;  14 700-708
    PubMedGoogle Scholar
  • 132 Dimitrakopoulou A, Strauss L, Clorius J. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma.  J Nucl Med . 1993;  34 1075-1081
    PubMedGoogle Scholar
  • 133 Dimitrakopoulou-Strauss A, Strauss L, Schlag P. Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma.  J Nucl Med . 1998;  39 1197-1202
    PubMedGoogle Scholar
  • 134 Moehler M, Dimitrakopoulou-Strauss A, Gutzler F. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.  Cancer . 1998;  83 245-253
    CrossrefPubMedGoogle Scholar
  • 135 Torizuka T, Tamaki N, Inokuma T. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.  J Nucl Med . 1994;  35 1965-1969
    PubMedGoogle Scholar
  • 136 Vitola J, Delbeke D, Meranze S, Mazer M, Pinson C. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolism.  Cancer . 1996;  78 2216-2222
    CrossrefPubMedGoogle Scholar